<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><description>赛柏蓝（Mic366）,中国医药行业专业的资讯信息分享互动平台，致力于及时、准确、有用！</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 20 Apr 2021 21:28:47 +0800</pubDate><image><url>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</url><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>关于医院黑幕，国家卫健委发声了</title><link>https://mp.weixin.qq.com/s/FLaBCTHs-B9FqkBJNNjylQ</link><description></description><content:encoded><![CDATA[关于医院黑幕，国家卫健委发声了]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>阿尔茨海默病原创新药九期一开启6+3慈善赠药</title><link>https://mp.weixin.qq.com/s/4kpUZnt4ZzI32uZeUSGgPw</link><description></description><content:encoded><![CDATA[阿尔茨海默病原创新药九期一开启6+3慈善赠药]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>最新 | 知名药企大动作</title><link>https://mp.weixin.qq.com/s/OcdMsc677DXX3okae-_vpQ</link><description></description><content:encoded><![CDATA[最新 | 知名药企大动作]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>又一重磅创新药，来了</title><link>https://mp.weixin.qq.com/s/VY4c6T_r2ZsM1eawTJKRjg</link><description></description><content:encoded><![CDATA[又一重磅创新药，来了]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>最新报告：中国医药市场，创新药仅占9%</title><link>https://mp.weixin.qq.com/s/Pp5ueLkByX-RvEsLeJPgOw</link><description></description><content:encoded><![CDATA[最新报告：中国医药市场，创新药仅占9%]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>恒瑞一季报出炉，高投入研发、股权激励竟“耽误”了盈利</title><link>https://mp.weixin.qq.com/s/kmCC_8TDi2-Rdy0_JKM5XA</link><description></description><content:encoded><![CDATA[恒瑞一季报出炉，高投入研发、股权激励竟“耽误”了盈利]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>三七与天麻素制剂，药物经济学评价高</title><link>https://mp.weixin.qq.com/s/-1Y8tA1NHBZ40N9me4r9NA</link><description></description><content:encoded><![CDATA[三七与天麻素制剂，药物经济学评价高]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>财政部：还有一批处罚名单待公布？</title><link>https://mp.weixin.qq.com/s/AO3QsUnRQ_uvFxMjulzTjQ</link><description></description><content:encoded><![CDATA[财政部：还有一批处罚名单待公布？]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:26:03 +0800</pubDate></item><item><title>最新！这些中药材涨价（附名单）</title><link>https://mp.weixin.qq.com/s/ltJiW-G0jrYJaNybsnWa0Q</link><description></description><content:encoded><![CDATA[最新！这些中药材涨价（附名单）]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>阿斯利康，收购知名药企</title><link>https://mp.weixin.qq.com/s/9GoLARW6kN1uNy_RH7XWlQ</link><description></description><content:encoded><![CDATA[阿斯利康，收购知名药企]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>药商发通知：一4+7品种，采购困难</title><link>https://mp.weixin.qq.com/s/s70SmDVYBSeM--IZMU481w</link><description></description><content:encoded><![CDATA[药商发通知：一4+7品种，采购困难]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>93个中药大卖：步长、丽珠、片仔癀...</title><link>https://mp.weixin.qq.com/s/fRyOgymAoXDAfhNb5_x1tQ</link><description></description><content:encoded><![CDATA[93个中药大卖：步长、丽珠、片仔癀...]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>药械代理商：2021年绝佳商机出现了</title><link>https://mp.weixin.qq.com/s/JZMcM73460q5xWHLdY0EdA</link><description></description><content:encoded><![CDATA[药械代理商：2021年绝佳商机出现了]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>这个首仿药，药店卖得好</title><link>https://mp.weixin.qq.com/s/OKwoLX7th6GN7HE6b1gtnw</link><description></description><content:encoded><![CDATA[这个首仿药，药店卖得好]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>阿斯利康再度亮相博鳌亚洲论坛，共话“互联网+医疗”新业态</title><link>https://mp.weixin.qq.com/s/bV1yMeL-exI4kTbM2SBtaw</link><description></description><content:encoded><![CDATA[阿斯利康再度亮相博鳌亚洲论坛，共话“互联网+医疗”新业态]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>国家带量采购，下一步新动作</title><link>https://mp.weixin.qq.com/s/Y3y8MfOn1Qn3O_GpG1Sodw</link><description></description><content:encoded><![CDATA[国家带量采购，下一步新动作]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:59:01 +0800</pubDate></item><item><title>后天！40个大品种集采，180家药企拼价格（附名单）</title><link>https://mp.weixin.qq.com/s/E7YwW1uZSX4z-834wDzO7Q</link><description></description><content:encoded><![CDATA[后天！40个大品种集采，180家药企拼价格（附名单）]]></content:encoded><pubDate>Sun, 18 Apr 2021 18:54:06 +0800</pubDate></item><item><title>最新 | 中国医院排行榜公布（附五大榜单）</title><link>https://mp.weixin.qq.com/s/W66oTypF6vIQOeRPlI257A</link><description></description><content:encoded><![CDATA[最新 | 中国医院排行榜公布（附五大榜单）]]></content:encoded><pubDate>Sun, 18 Apr 2021 18:54:06 +0800</pubDate></item><item><title>药代才能听懂的「行话」来了</title><link>https://mp.weixin.qq.com/s/EE7DI7MwEKOqgdFH92z7Xw</link><description></description><content:encoded><![CDATA[药代才能听懂的「行话」来了]]></content:encoded><pubDate>Sun, 18 Apr 2021 18:54:06 +0800</pubDate></item><item><title>双联合双动力，“天晴杯”赋能连锁慢病管理新体系</title><link>https://mp.weixin.qq.com/s/Fa7x4VPDs1hwmkYnlVvZOg</link><description></description><content:encoded><![CDATA[双联合双动力，“天晴杯”赋能连锁慢病管理新体系]]></content:encoded><pubDate>Sun, 18 Apr 2021 18:54:06 +0800</pubDate></item></channel></rss>